000 01218 a2200325 4500
005 20250515172925.0
264 0 _c20091102
008 200911s 0 0 spa d
022 _a1130-6343
040 _aNLM
_beng
_cNLM
100 1 _aPérez Rodrigo, I
245 0 0 _a[Effectiveness and safety of erlotinib in 2 patients with carcinoma of the cervix].
_h[electronic resource]
260 _bFarmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
_c
300 _a96-9 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAged
650 0 4 _aErbB Receptors
_xantagonists & inhibitors
650 0 4 _aErlotinib Hydrochloride
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMiddle Aged
650 0 4 _aQuinazolines
_xtherapeutic use
650 0 4 _aRetrospective Studies
650 0 4 _aUterine Cervical Neoplasms
_xdrug therapy
700 1 _aAlbornoz López, R
700 1 _aSoto Rojas, M
700 1 _aFernández García, I
700 1 _aTorres Degayón, V
773 0 _tFarmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
_gvol. 33
_gno. 2
_gp. 96-9
999 _c18905835
_d18905835